ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

HOOK HOOKIPA Pharma Inc

0.7871
-0.0399 (-4.82%)
Fuera de horario
Última actualización: 16:08:07
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
HOOKIPA Pharma Inc HOOK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0399 -4.82% 0.7871 16:08:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.845 0.791 0.8499 0.80 0.827
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
24/4/202406:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
16/4/202415:30GLOBEHOOKIPA Pharma Announces Grant of Inducement Award Under..
10/4/202406:01GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
22/3/202406:01GLOBEHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
06/3/202406:01GLOBEHOOKIPA Pharma to Participate in Leerink Partners Global..
31/1/202415:30EDGAR2Form 8-K - Current report
29/1/202407:12EDGAR2Form 8-K - Current report
29/1/202407:01GLOBEHOOKIPA Pharma Provides Update on Business Priorities and..
16/1/202406:01GLOBEHOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
04/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
22/12/202306:33EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202306:06EDGAR2Form 8-K - Current report
21/12/202306:01GLOBEHOOKIPA Pharma Announces $21.25 Million Equity Investment..
01/12/202315:46EDGAR2Form 8-K - Current report
20/11/202306:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
09/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:05EDGAR2Form 8-K - Current report
09/11/202306:01GLOBEHOOKIPA Pharma Reports Third Quarter 2023 Financial..
03/11/202311:01GLOBEHOOKIPA Pharma Presents Positive Biomarker and Translational..
02/11/202315:01GLOBEHOOKIPA Pharma to Report Third Quarter 2023 Financial..
22/10/202305:01GLOBEHOOKIPA Pharma Presents Additional Preliminary Phase 2 Data..
20/10/202315:05EDGAR2Form 8-K - Current report
18/10/202306:01GLOBEHOOKIPA Pharma announces publication of preclinical data of..
13/9/202307:47EDGAR2Form 8-K - Current report
13/9/202307:45GLOBEHOOKIPA Announces Executive Leadership Change
12/9/202307:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/9/202306:01GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
06/9/202306:01GLOBEHOOKIPA Pharma to participate in upcoming investor..
22/8/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:13EDGAR2Form SC TO-I - Tender offer statement by Issuer
10/8/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:05EDGAR2Form 8-K - Current report
10/8/202306:01GLOBEHOOKIPA Pharma Reports Second Quarter 2023 Financial Results..
04/8/202315:10EDGAR2Form 8-K - Current report
03/8/202306:01GLOBEHOOKIPA Pharma to Report Second Quarter 2023 Financial..
03/7/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202304:00GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
31/5/202320:30GLOBEHOOKIPA Pharma Announces Pricing of $50.0 Million Public..
31/5/202315:45GLOBEHOOKIPA Pharma Announces Positive Preliminary Phase 2 Data..
11/5/202306:01GLOBEHOOKIPA Pharma Reports First Quarter 2023 Financial..
09/5/202306:01GLOBEHOOKIPA Announces First Person Dosed in Phase 1a/b Clinical..

Su Consulta Reciente

Delayed Upgrade Clock